Thermo Fisher Scientific (TMO) Operating Margin (2009 - 2026)

Thermo Fisher Scientific has disclosed Operating Margin across 18 years of filings, most recently posting 16.93% for Q1 2026.

• Quarterly Operating Margin rose 37.0% year-over-year to 16.93% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.46% (up 24.0% YoY) and the FY2025 annual result came in at 17.38%, up 27.0% from the prior year.
• Operating Margin eased to 16.93% in Q1 2026, from 18.46% in the prior quarter.
• Over five years, Operating Margin peaked at 23.87% in Q2 2022 and troughed at 14.59% in Q2 2023.
• A 5-year average of 17.24% and a median of 17.03% in 2023 frame the typical range for Operating Margin.
• Annual changes were most pronounced in 2023 — Operating Margin tumbled 928 bps — and 2024, when it jumped 250 bps.
• Tracing TMO's Operating Margin over 5 years: stood at 16.25% in 2022, then increased by 5 bps to 17.03% in 2023, then grew by 4 bps to 17.69% in 2024, then rose by 4 bps to 18.46% in 2025, then retreated by 8 bps to 16.93% in 2026.
• Business Quant data shows TMO's Operating Margin at 16.93% in Q1 2026, 18.46% in Q4 2025, and 17.45% in Q3 2025.